Why do patients with metastatic breast cancer (MBC) continue to have bone destruction despite bisphosphonate (BP) use? A pathologic review

Autor:	Gurmit Singh, C. Gainford, W.S. Ooi, Marion Kalina, Snezana Popovic, Mark Clemons, H. Kahn
Rok vydání:	2006
Předmět:	Oncology CA15-3 medicine.medical_specialty Histology Physiology business.industry Endocrinology Diabetes and Metabolism medicine.medical_treatment Bisphosphonate medicine.disease Metastatic breast cancer Breast cancer Internal medicine medicine business
Zdroj:	Bone. 38:81
ISSN:	8756-3282
DOI:	10.1016/j.bone.2006.01.044
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1c57a22a74a6a2194aebca80b47936f5 https://doi.org/10.1016/j.bone.2006.01.044 Zobrazit plný text záznamu Full Text from ScienceDirect